A microfluidic assay for the quantification of the metastatic propensity of breast-cancer specimens

The challenge of predicting which patients with breast cancer will develop metastases leads to the overtreatment of patients with benign disease and to the inadequate treatment of the aggressive cancers. Here, we report the development and testing of a microfluidic assay that quantifies the abundanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yankaskas, Christopher L., Thompson, Keyata N., Paul, Colin D., Vitolo, Michele I., Mistriotis, Panagiotis, Mahendra, Ankit, Bajpai, Vivek K., Shea, Daniel J., Manto, Kristen M., Chai, Andreas C., Varadarajan, Navin, Kontrogianni-Konstantopoulos, Aikaterini, Martin, Stuart S., Konstantopoulos, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563615/
https://www.ncbi.nlm.nih.gov/pubmed/31061459
http://dx.doi.org/10.1038/s41551-019-0400-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563615/
https://www.ncbi.nlm.nih.gov/pubmed/31061459
http://dx.doi.org/10.1038/s41551-019-0400-9

Ejemplares similares